Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)
Clinical trial NCT01614886 · COMPLETED
Trial details
- NCT number
- NCT01614886
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.